Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Corero Network Security ( (GB:CNS) ) just unveiled an update.
Corero Network Security announced that Ashley Stephenson, the Chief Technology Officer, has stepped down from the company’s board and will retire at the end of 2025. His departure marks the end of a significant era for Corero, as he played a crucial role in developing the company’s industry-leading DDoS protection solutions over his twelve-year tenure. This change in leadership could impact Corero’s strategic direction and innovation in the cybersecurity sector.
The most recent analyst rating on (GB:CNS) stock is a Hold with a £10.00 price target. To see the full list of analyst forecasts on Corero Network Security stock, see the GB:CNS Stock Forecast page.
Spark’s Take on GB:CNS Stock
According to Spark, TipRanks’ AI Analyst, GB:CNS is a Neutral.
Corero Network Security’s overall stock score is primarily influenced by its solid financial performance, despite challenges in cash flow management. The technical analysis indicates a bearish trend, and the valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively result in a moderate overall score.
To see Spark’s full report on GB:CNS stock, click here.
More about Corero Network Security
Corero Network Security is a leading provider of DDoS protection solutions, offering real-time, automated detection and mitigation with deep network visibility and analytics. The company protects critical infrastructure through its SmartWallONETM solution and CORE ecosystem, serving diverse deployment models from inline to edge to hybrid cloud. Corero operates from Marlborough, Massachusetts, USA, and Edinburgh, UK, and is listed on the London Stock Exchange’s AIM market and the US OTCQX Market.
Average Trading Volume: 304,391
Technical Sentiment Signal: Sell
Current Market Cap: £56.34M
For a thorough assessment of CNS stock, go to TipRanks’ Stock Analysis page.